Delivery Order SPE2DB20D3104-SPE2DB24FV6F3
- Not listed
- This federal contract award, valued at $1,097.08, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, and has an ultimate completion date of March 8, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen Drug Corp is a major...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,097.08 firm fixed-price delivery order is for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a specialty medication. The contract has an ultimate completion date of December 14, 2023. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award, valued at $1,947.86, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract has an ultimate completion date of October 10, 2023 and is a Firm Fixed Price Delivery Order. The award was made without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award, valued at $5,481.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract is a Firm Fixed Price Delivery Order with a completion date of March 9, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) valued at up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,448.10 firm fixed price delivery order is for WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a completion date of July 8, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,387.34 and a performance period ending on January 30, 2024. The contract is a Firm Fixed Price Delivery Order, and no set-aside designation was used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role...
- This federal contract award, valued at $7,992.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a specialty medication, to support federal healthcare programs. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,194.16 firm fixed-price delivery order is for WEGOVY 1 MG/0.5 ML PEN 0.5ML, with an ultimate completion date of February 2, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and both companies are for-profit organizations registered in the System for Award Management (SAM.gov). Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,909.84 firm fixed-price delivery order is for WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a period of performance through March 24, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $7,643.33 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of June 9, 2023 and was not set aside for any specific business category. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB24FV6F3Delivery Order
This federal contract award, valued at $24,108.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 16, 2024. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued at up to $999,999,999.00, and the Department of Justice Federal Bureau of Investigation, valued at up to $750,000.00, which serve as primary vehicles for delivering a comprehensive range of pharmaceutical products and medical supplies to support various federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.1k | 4/15/24 |